SeaSpine
Net sales: $47.5 million (+66 percent)
U.S. sales: $42.6 million (+64 percent)
U.S. spinal implants and enabling technologies sales: $21.4 million (+62 percent)
U.S. orthobiologics sales: $21.2 million (+67 percent)
Orthofix
Net sales: $121 million (+66 percent)
Global spine sales: $94.7 million (+62.5 percent)
Global orthopedic sales: $26.7 million (+66 percent)
Smith+Nephew
Net sales: $1.3 million (+48.2 percent)
Orthopedic sales: $557 million (+53 percent)
Knee sales: $226 million (+65.5 percent)
Hip sales: $161 million (+43.6 percent)
Trauma and extremities sales: $149 milloin (+44.3 percent)
Sports medicine joint repair sales: $211 million (+63.6 percent)
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
